Celltrion Healthcare Stock Price at 95,200 KRW... Up 0.95% from Previous Day
As of 10:33 AM on the 15th, Celltrion Healthcare is trading at 95,200 KRW, up 0.95% from the previous day. This marks an 18.85% increase compared to April 20. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have a net sell of 20,000 shares of Celltrion Healthcare, while institutions have a net buy of 5,000 shares, according to provisional data. Over the past five days, individual investors have net sold 1,065,272 shares, whereas foreigners and institutions have net bought 292,625 shares and 779,246 shares, respectively.
On May 8, Celltrion Healthcare was a market highlight for its "strength due to expansion of the immune therapy product sales network in Europe."


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Special Prosecutor Requests Arrest Warrant for Former KTV President Lee Eunwoo on Charges of Incitement of Insurrection
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.